Dassault Systemes

Dassault Systèmes’ Life Sciences Forum

The live, in-person, 1-day Life Sciences Forum will allow participants to discover how Dassault Systèmes’ solutions enable Digital Transformation in Research, Therapeutics & Clinical Development and Manufacturing for the Pharmaceutical, BioTech and Medical Device Industries to meet today’s ever-evolving business needs.

Rising renewables

Gemma Church examines how simulation and modelling aid the increasingly diverse renewable energy field

Dassault Systèmes acquires Medidata Solutions

Dassault Systèmes and Medidata Solutions have announced an agreement for Dassault Systèmes to acquire Medidata in an all-cash transaction at a price of $ 92.25 per share of Medidata, representing an enterprise value of $5.8 billion. The transaction was unanimously approved by the Boards of Directors of both companies.

Fattening up FEA

Gemma Church discusses advances to FEA software as it is now used to simulate a wide range of physical phenomena


Subscribe to RSS - Dassault Systemes